BioRestorative Therapies Inc. (NASDAQ: BRTX)
$1.77
N/A ( 0% ) 13.2K
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
Market Data
Open
$1.77
Previous close
$1.77
Volume
13.2K
Market cap
$11.98M
Day range
$1.78 - $1.87
52 week range
$1.03 - $3.67
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Sep 06, 2023 |
4 | Insider transactions | 1 | Aug 31, 2023 |
10-q | Quarterly Reports | 54 | Aug 11, 2023 |
def | Proxies and info statements | 3 | Aug 04, 2023 |
4 | Insider transactions | 1 | Jul 28, 2023 |
4 | Insider transactions | 1 | Jul 25, 2023 |
8-k | 8K-related | 17 | Jul 13, 2023 |